List of insiders holdings for AGIOS PHARMACEUTICALS INC.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
# | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
1 | CELGENE CORP Celgene European Investment Co LLC Celgene Switzerland LLC Celgene Alpine Investment Co. LLC 10% Owner | 2019-11-14 16:07:11 | 7,121,658 0 | 7,121,658 | Form 13D |
2 | STARR KEVIN P Director 10% Owner | 2015-02-19 19:01:33 | 342,253 4,590,480 | 4,932,733 | Form 4 |
3 | THIRD ROCK VENTURES LP Third Rock Ventures GP L.P. TRV GP LLC 10% Owner | 2015-02-19 19:03:37 | 4,590,480 0 | 4,590,480 | Form 4 |
4 | Flagship Ventures Fund 2007 L.P. AFEYAN NOUBAR KANIA EDWIN M JR Flagship Ventures 2007 General Partner LLC 10% Owner | 2017-02-13 14:25:03 | 965,369 0 | 965,369 | Form 13G |
5 | Mak Tak W. 10% Owner | 2013-07-23 20:23:06 | 545,454 0 | 545,454 | Form 3 |
6 | Higgons John Duncan Chief Operating Officer | 2016-01-05 17:20:30 | 483,035 0 | 483,035 | Form 4 |
7 | Goff Brian Chief Executive Officer | 2025-03-04 16:10:25 | 318,345 0 | 318,345 | Form 4 |
8 | Cantley Lewis Clayton Jr. Director | 2017-12-08 16:23:42 | 79,475 121,121 | 200,596 | Form 4 |
9 | FOUSE JACQUALYN A Director | 2025-04-10 16:02:58 | 149,220 0 | 149,220 | Form 4 |
10 | Gheuens Sarah Chief Medical Officer | 2025-03-04 16:08:38 | 124,730 0 | 124,730 | Form 4 |
11 | Hoerter Steven L. Chief Commercial Officer | 2019-03-05 16:04:05 | 117,241 0 | 117,241 | Form 4 |
12 | Jones Cecilia Chief Financial Officer | 2025-03-04 16:15:12 | 110,572 0 | 110,572 | Form 4 |
13 | NELSEN ROBERT Director | 2017-03-07 16:35:15 | 109,230 0 | 109,230 | Form 4 |
14 | Goddard Glenn Senior Vice President, Finance | 2016-02-18 17:15:42 | 108,572 0 | 108,572 | Form 4 |
15 | Burns James William Chief Legal Officer | 2025-03-04 16:17:01 | 108,041 0 | 108,041 | Form 4 |
16 | Milanova Tsveta Chief Commercial Officer | 2025-03-04 16:12:59 | 89,725 0 | 89,725 | Form 4 |
17 | Biller Scott Chief Scientific Officer | 2019-06-13 16:07:42 | 33,729 53,059 | 86,788 | Form 4 |
18 | Viswanadhan Krishnan Chief Corp Dev & Strategy | 2025-03-07 16:18:52 | 79,674 0 | 79,674 | Form 4 |
19 | Ballal Rahul D. Director | 2024-11-12 16:09:38 | 53,886 0 | 53,886 | Form 4 |
20 | Car Bruce Chief Scientific Officer | 2022-03-03 16:11:46 | 52,500 0 | 52,500 | Form 4 |
21 | Biller Jonathan Chief Financial Officer | 2022-03-03 16:12:19 | 52,500 0 | 52,500 | Form 4 |
22 | Tessier-Lavigne Marc Director | 2016-06-23 16:10:18 | 48,875 0 | 48,875 | Form 4 |
23 | Scadden David Director | 2024-12-13 16:04:41 | 44,590 0 | 44,590 | Form 4 |
24 | Hirsch Andrew Chief Financial Officer | 2020-04-24 16:06:36 | 36,057 0 | 36,057 | Form 4 |
25 | Clancy Paul J Director | 2022-06-23 16:09:40 | 34,282 0 | 34,282 | Form 4 |
26 | Washburn Theodore James Jr. Principal Accounting Officer | 2025-03-04 16:06:56 | 30,891 0 | 30,891 | Form 4 |
27 | MARAGANORE JOHN Director | 2023-02-03 16:06:03 | 28,528 0 | 28,528 | Form 5 |
28 | KARSEN PERRY A Director | 2015-06-25 18:26:53 | 23,125 0 | 23,125 | Form 4 |
29 | Bowden Christopher Chief Medical Officer | 2021-06-22 16:44:19 | 16,479 0 | 16,479 | Form 4 |
30 | Schenkein David P Director | 2024-06-24 16:09:40 | 13,894 0 | 13,894 | Form 4 |
31 | CAPELLO JEFFREY D Director | 2024-06-24 16:10:35 | 13,894 0 | 13,894 | Form 4 |
32 | Foster-Cheek Kaye I Director | 2024-06-24 16:10:11 | 13,894 0 | 13,894 | Form 4 |
33 | Ho Maykin Director | 2024-06-24 16:10:01 | 13,894 0 | 13,894 | Form 4 |
34 | Owen Catherine E. Director | 2024-06-24 16:09:50 | 13,894 0 | 13,894 | Form 4 |
35 | Smith Cynthia Director | 2024-08-13 16:12:40 | 10,294 0 | 10,294 | Form 4 |
36 | Poddar Richa Chief Commercial Officer | 2022-10-18 16:17:10 | 8,508 0 | 8,508 | Form 4 |
37 | Miles Darrin Chief Commercial Officer | 2021-05-18 16:11:40 | 7,209 0 | 7,209 | Form 4 |
38 | CLARK IAN T Director | 2022-05-24 16:12:10 | 6,549 0 | 6,549 | Form 4 |
39 | Cole Douglas G. Director | 2016-08-11 16:33:47 | 3,695 0 | 3,695 | Form 4 |
40 | Alenson Carman Principal Accounting Officer | 2021-06-23 17:28:44 | 3,555 0 | 3,555 | Form 4 |
41 | Arch Venture Fund VII LP ARCH Venture Partners VII L.P. ARCH Venture Partners VII LLC CRANDELL KEITH BYBEE CLINTON 10% Owner | 2016-02-11 12:24:08 | 0 0 | 0 | Form 13G |